Showing 2321-2330 of 2735 results for "".
- Teyana Taylor Tapped as New Xeomin Brand Partnerhttps://modernaesthetics.com/news/teyana-taylor-tapped-as-new-xeomin-brand-partner/2473321/Xeomin, an FDA-approved double filtered anti-wrinkle injection to temporarily improve the appearance of frown lines with only the ingredients that work and none that don’t. “I always strive to understand the ingredients in any product I’m using and listen to trusted so
- Aesthetic One App Registers More than 22,000 Breast Implantshttps://modernaesthetics.com/news/aesthetic-one-app-has-registered-more-than-22000-breast-implants/2473320/More than 12,000 patients now have on-demand access to their breast implant details thanks to Aesthetic One, a free app developed through support From Allergan Aesthetics and built by The Aesthetic Society's technology partner
- FDA Clears Aesthetics Biomedical's Vivace Ultrahttps://modernaesthetics.com/news/fda-clears-aesthetics-biomedicals-vivace-ultra/2473317/The FDA has cleared Aesthetics Biomedical Inc.’s Vivace Ultra, the next generation and of personalized aesthetics, for use in dermatologic and general surgical procedures for electrocoagulation and hemostasis. An innovative reimagination and technical upgrade of the legacy Vivace
- Hugel Resubmits BLA for Botulaxhttps://modernaesthetics.com/news/hugel-resubmits-bla-for-botulax/2473314/Hugel resubmitted the BLA for its botulinum toxin called Botulax for smoothing glabellar lines to the U.S. FDA. Hugel had received a Complete Response Letter (CRL) from the U.S. FDA last March after submitting the BLA for Botulax (50 and 100 units) to advance into the U.S. market i
- Curtis Cluff Named President and CFO of BioPhotas Inc.https://modernaesthetics.com/news/curtis-cluff-named-president-and-cfo-of-biophotas-inc/2473313/Curtis Cluff is the new President and Chief Financial Officer BioPhotas Inc., manufacturers of the Celluma series of light therapy devices. In this newly created role, Mr. Cluff will report to Patrick Johnson, Chief Executive Officer and inventor of the Celluma. &quo
- Power Move: UFC Performance Institute to Use Lutronic Accufit for Training, Rehabhttps://modernaesthetics.com/news/power-move-ufc-performance-institute-to-use-lutronic-accufit-for-training-rehab/2473308/Lutronic's Accufit will now be made available for use to UFC fighters and other elite athletes through the UFC Performance Institute. "Accufit provides a higher energy multi-dimensional muscle workout, and the body contouring iprovement is dramatic. This 3rd generation intellig
- L'Oréal USA to Open New Research & Innovation Center in New Jerseyhttps://modernaesthetics.com/news/loreal-usa-to-open-new-research-innovation-center-in-new-jersey/2473305/L'Oréal USA is opening a new, state-of-the-art Research & Innovation (R&I) Center in Clark, New Jersey, replacing its existing facilities that it has occupied in the area for more than six decades. The $140 million development project represents the most significant investment
- Merz Aesthetics Introduces New Lookhttps://modernaesthetics.com/news/merz-aesthetics-introduces-new-look/2473303/Merz Aesthetics has debuted a new corporate visual identity. According to the company, the refreshed look underscores its commitment to putting the definition of beauty back into the hands of the individual through a vibrant and distinct color palette along with strong and joyful photography.
- BuildMyHealth Names First Chief Revenue Officerhttps://modernaesthetics.com/news/buildmyhealth-points-first-chief-revenue-officer/2473302/BuildMyHealth, developer of the No Surprises Act price transparency and lead conversion platform, has its first Chief Revenue Officer. Chad Sawyer was previously a national sales executive with both Crystal Clear Digital Marketing and Patient Now. In those roles, Mr. Sawyer helped hundreds of pra
- BeautyHealth’s Hydrafacial Partners with Organicell for Exosome Boosterhttps://modernaesthetics.com/news/beautyhealths-hydrafacial-partners-with-organicell-for-exosome-booster/2473300/The Beauty Health Company is joining forces with biotech company Organicell to co-create a first-to-market exosome booster that will address signs of aging and inflammation in the skin for Hydrafacial. “We are excited to begin development with Organicell to co-create a potentially